Mr. Rob Carducci reports

GLOW LIFETECH GRANTS STOCK OPTIONS

Glow Lifetech Corp. has granted 3.05 million stock options to various directors, officers, employees and consultants of the company. Each option is exercisable at a price of six cents for one common share of the company for a period of five years from the date of grant and are being issued under the terms of the company's omnibus long-term incentive plan. The options, and any common shares issued upon exercise of the options, are subject to a four-month-and-one-day resale restriction from the date of grant.

The aforementioned grant of options resulted in certain insiders of the company receiving an aggregate of 2.4 million stock options. The company has relied on the exemptions from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions (MI 61-101), contained in Section 5.5(b) and 5.7(a) of MI 61-101 in respect of such insider participation.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.